Status:
COMPLETED
CYP2D6 Polymorphism in Patients of General Practice in Austria
Lead Sponsor:
Karl Landsteiner Institute for Systematics in General Medicine
Conditions:
Disorder Due Cytochrome P450 CYP2D6 Variant
Eligibility:
All Genders
18-100 years
Brief Summary
The CYP 2D6 enzyme metabolizes a significant number of drugs frequently prescribed in general practice/ family medicine. Various genetically different variants define if the patient is an ultra-rapid ...
Detailed Description
Study population: Unselected consecutive patients of the practice office visiting the surgery for a routine blood sampling due to various medical conditions and who are prescribed or have been prescr...
Eligibility Criteria
Inclusion
- Patients with clinical diagnosis of hypertension, diabetes, chronic heart failure, hyperlipidemias, depression, schizophrenia, cardial arrhythmias, thyroid diseases and dementia
Exclusion
- acute infectious diseases
Key Trial Info
Start Date :
October 9 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 9 2018
Estimated Enrollment :
289 Patients enrolled
Trial Details
Trial ID
NCT03859622
Start Date
October 9 2017
End Date
October 9 2018
Last Update
October 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Practice Office
Angern, Lower Austria, Austria, A 2261